Evofem Biosciences (PK) Stock Price

0.00 (0.0%)
Volume 0.00
Bid Price 0.1701
Ask Price 0.187
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Evofem Biosciences Inc (PK) EVFM OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.1768 08:03:08
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
0 0.00 - 0.16 - 0.479
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.1768 USD


Draw Mode:

Evofem Biosciences Inc (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 17.14M 96.95M 81.06M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
3.36M $ - - - -

more financials information »

Evofem Biosciences (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical EVFM Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.2230.2330.160.18956793,203,918-0.0462-20.72%
1 Month0.3750.400.160.24352141,893,295-0.1982-52.85%
3 Months0.38990.4790.160.32658922,189,785-0.2131-54.66%
6 Months0.38990.4790.160.32658922,189,785-0.2131-54.66%
1 Year0.38990.4790.160.32658922,189,785-0.2131-54.66%
3 Years0.38990.4790.160.32658922,189,785-0.2131-54.66%
5 Years0.38990.4790.160.32658922,189,785-0.2131-54.66%

Evofem Biosciences (PK) Description

Evofem Biosciences, Inc. is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from chlamydia and gonorrhea. The Company's first FDA-approved product, Phexxi (lactic acid, citric acid and potassium bitartrate), is a hormone-free, on-demand prescription contraceptive vaginal gel. It comes in a box of 12 pre-filled applicators and is applied 0-60 minutes before each act of sex. The Company expects to report top-line data this fall from its registrational Phase 3 EVOGUARD clinical trial evaluating Phexxi for two potential new indications prevention of chlamydia and prevention of gonorrhea in women.
Your Recent History
Evofem Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220927 12:27:12